car-engineered nk cells for targeting cd25 in cml blast crisis
Published 8 months ago • 101 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
1:30
insights into nkg2d-targeting car-t cells in r/r aml
-
8:54
ft596: ipsc-derived car-nk cells with engineered persistence for b-cell malignancies
-
1:37
the use of bispecifics and car t-cells in south america: challenges that remain
-
2:30
car t-cells vs. car nk-cells
-
4:22
carcik trial updates: using sb-engineered car-t cells in patients with b-all
-
1:49
are car nk-cells the future of cll therapy?
-
2:56
car-nk clinical trials
-
0:45
bispecific car t-cell therapy: combining anti-cd19 and cd22 car t-cells
-
3:18
evaluating dual-targeting cd19/22 car-t cells in patients with r/r all
-
1:35
key mechanisms of resistance to car t-cell therapy
-
1:15
harnessing nk cells for cancer immunotherapies
-
1:32
car t cell therapy explained (animation) | city of hope
-
5:14
nk-cell enhancement: trail variant
-
2:03
engineering multi-antigenic car t-cells for aml
-
7:40
immunotherapy for aml and all: checkpoint inhibitors & car t-cells for b-cell all
-
3:51
universal “off-the-shelf” car t-cells from ipscs
-
1:27
car t-cells in all: an overview
-
3:39
car t-cells and crispr: the future of aml treatment
-
1:21
anti-cd22 car t-cell therapy for all: trial update, utility for salvage and cd19 status